drug screening

drug screening

Clinical toxicology A method for identifying the presence of one or more drugs of abuse, usually in urine, by 'stat' methods–eg, EMIT–enzyme-mediated immunologic technique, FPIA–fluorescence polarization immunoassay, TLC; DS is used in the ER, for preemployment testing, and identifies the most commonly abused substances–eg, cocaine, opiates, tranquilizers, sedatives–barbiturates, and hallucinogens–PCP, LSD, tetrahydrocannabinol
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
iPSC-derived hepatocytes can be produced from potentially any donor, allowing a wide spectrum of the population to be studied in future drug screening experiments.
M2 PHARMA-February 11, 2014-LIMSABC unveils LIMS software for toxicology drug screening labs
M2 EQUITYBITES-March 22, 2012-VistaGen Therapeutics Inc signs strategic drug screening collaboration with Vala Sciences Inc(C)2012 M2 COMMUNICATIONS http://www.m2.com
This discovery is a firm foundation on which we will broaden and deepen our novel drug screening capabilities"
With a volume range from the low nanoliters to milliliters, a 20 position deck, and wide range of useful accessories, the Sciclone ALH 3000 can be used to automate virtually any genomic, proteomic, or drug screening protocol.
With the increase in LSD and other illicit drug use, urine drug screening in occupational and clinical settings has likewise increased.
The company is primarily focused on the rapidly growing areas of drug screening, functional genomics and proteomics.
"It's a low cost alternative for our drug screening pro gram, and it allows us to offer better services to our clients," Reeves says.
In addition, the researchers want the regulatory agencies to revamp the current drug screening process, which doesn't look for tumor promotion at clinically relevant doses.
NESS ZION A, Israel, August 4, 2014 -- Israeli biotechnology company Kadimastem (TASE: KDST) reports that it has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis (MS), and potential other neurodegenerative diseases.